Fibroin-like Protein Production in E. coli via Acetic Acid Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The production of fibroin-like proteins using Escherichia coli is hindered by acetic acid accumulation, which inhibits protein expression and cell growth, particularly when using inducible promoters like the tryptophan promoter, and existing methods do not effectively manage acetic acid concentrations during protein induction.

Innovation Solution

The method involves culturing Escherichia coli with a fibroin-like protein gene under the control of a tryptophan promoter, where the expression is induced by depleting tryptophan or adding 3-beta-indoleacrylic acid, while maintaining low glucose uptake rates to reduce acetic acid accumulation, thereby enhancing protein production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If heterogeneous expression of fibroin-like protein is performed using Escherichia coli, then protein production is achieved, but acetic acid accumulates in the medium which inhibits cell growth and reduces expression amount

Engineering Contradiction:
Improveprotein productionVSAvoidacetic acid accumulation
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by controlling glucose addition timing and rate before protein expression begins. The culture is maintained in exponential growth phase with controlled glucose supplementation to prevent acetic acid accumulation before the induction step, creating optimal conditions for subsequent high-level protein expression without inhibition

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs parameter changes by optimizing multiple process parameters including glucose concentration (0.1-10 g/L), aeration rate (0.1-2.0 L/min), agitation speed (50-200 rpm), and induction timing. These parameter adjustments control metabolic flux to prevent acetic acid accumulation while maintaining high protein expression levels

Inventive Principle:
Principle #35Parameter changes

2Reliability

If acetic acid concentration is controlled at low levels during continuous culture, then cell growth is maintained, but specific production rate of protein is reduced

Engineering Contradiction:
Improvecell growthVSAvoidspecific production rate
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent applies preliminary action by establishing optimal growth conditions with controlled glucose addition before protein induction. The culture reaches exponential growth phase with low acetic acid levels, then induction is triggered to achieve high production rates without the growth inhibition that would occur if induction happened under acidic conditions

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses periodic action through intermittent glucose feeding and controlled aeration cycles. Glucose is added periodically to maintain carbon source supply while controlling accumulation, and aeration is adjusted periodically to manage acetate oxidation, enabling both sustained growth and high production rates

Inventive Principle:
Principle #19Periodic action

3Object-affected harmful factors

If glucose uptake rate is reduced to lower acetic acid accumulation, then acetic acid concentration decreases, but protein expression induction may be affected

Engineering Contradiction:
Improveacetic acid concentrationVSAvoidprotein expression level
Core Design Contradiction:
Object-affected harmful factorsVSProductivity

Solution Approach 1:

The patent applies preliminary action by maintaining low glucose uptake rates during the growth phase to prevent acetic acid accumulation, then triggering protein expression induction at the optimal moment when cells are in exponential growth phase with low acetate levels. This timing ensures high expression without acetic acid inhibition

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs parameter changes by dynamically adjusting glucose concentration (0.1-10 g/L), aeration rate (0.1-2.0 L/min), and induction timing to decouple glucose uptake rate from acetic acid accumulation. These adjustments allow low acetate levels to be maintained while achieving high protein expression through controlled induction

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach improves the production of fibroin-like proteins by minimizing acetic acid accumulation, leading to increased expression levels and reduced inhibition, resulting in more efficient protein accumulation and cell growth.

Implementation Method 1

It is known that, in heterogeneous expression of a protein using Escherichia coli, accumulation of acetic acid in the medium correlates with reduction of cell growth and reduction of expression amount of protein

Methodology Applied
Scientific EffectFermentation: Fermentation

Implementation Method 2

A tryptophan promoter (trp promoter) is an inducible promoter. It has been known that gene expression from the trp promoter can be induced by, for example, depletion of tryptophan (Trp) or addition of 3-beta-indoleacrylic acid (IAA)

Methodology Applied
Scientific EffectInducible promoter mechanism:

Data Source

PatentEP3382031B1Method for producing fibroin-like protein
Publication Date: 2023.11.29 AJINOMOTO CO INC
  • EP3382031B1 patent drawingFigure 1(A)~1(B)
  • EP3382031B1 patent drawingFigure 2(A)~2(B)
  • EP3382031B1 patent drawingFigure 3(A)~3(B)

AI summary

A method for producing a fibroin-like protein is provided. A fibroin-like protein is produced by a method for producing a fibroin-like protein comprising culturing Escherichia coli having a gene encoding the fibroin-like protein in a medium, inducing expression of the gene encoding the fibroin-like protein, and collecting the fibroin-like protein, wherein accumulation of an organic acid at the time of inducing the expression is reduced, and wherein the gene is expressed under control of a tryptophan promoter.